How to evaluate research peptides before you order

The standard analytical method for synthetic peptide purity is reversed-phase high-performance liquid chromatography (RP-HPLC), typically with a C18 column and UV detection at 214 nm, the wavelength where peptide bonds (amide bonds) absorb most strongly^[2]. The output is a chromatogram in which each component is integrated by area, and "98% purity" means 98% of the detected area corresponds to the target peptide.

What the published guidance recommends

Reference standards published by USP follow a two-step process: bulk material purity is determined by measuring all detectable impurities (peptide-related impurities, counter ion, residual solvents, water, non-combustible residues) and subtracting from 100%^[1]. For most research-grade applications, cell-based assays, receptor binding, signalling studies, ≥98% HPLC purity is the accepted floor^[1].

What to ask the supplier

• What is the HPLC method (column, wavelength, gradient)?
• Is the purity stated per batch, or as a typical or average value?
• Can I see the actual chromatogram, not just the percentage?

HPLC purity does not confirm identity. A peptide can be 99% pure and still be the wrong molecule, chromatography measures the proportion of target peptide in the sample, not the molecular structure. Identity is confirmed by mass spectrometry, typically electrospray ionization MS (ESI-MS), which reports the actual molecular weight of the dominant species in the sample^[1].

A complete certificate of analysis pairs the two: HPLC chromatogram (purity) plus MS spectrum (identity), both tied to the batch number you're buying. If a supplier provides one without the other, the COA is incomplete by the published standard.

Synthetic peptides are produced by solid-phase peptide synthesis (SPPS), most commonly using the Fmoc/tBu strategy^[3]. SPPS produces predictable byproducts, and a literate research lab knows what to watch for:

• Truncation sequences, chains missing one or more terminal residues. These can compete for the same binding sites as the intact peptide and confound dose-response data.
• Deletion sequences, chains missing internal residues. Harder to detect by purity alone; show up clearly on MS.
• Oxidized variants (+16 Da per oxidized residue) and deamidated variants (+1 Da). Common with methionine, cysteine, glutamine, asparagine residues.
• Trifluoroacetic acid (TFA) salts, residue from the SPPS cleavage step. TFA is well-documented to interfere with cell-based assays and can be cytotoxic at concentrations that don't show up on HPLC^[3].

None of these are exotic, they're the standard impurity profile of SPPS-produced peptides. The question for a supplier isn't whether they exist, it's whether they characterize and quantify them, or whether the COA reports a single purity number with no breakdown of the rest.

Lyophilization (freeze-drying) reduces the residual moisture in a peptide sample to under 1%. This is the most important single factor in peptide stability, because virtually all significant degradation pathways, hydrolysis, deamidation, oxidation in solution, require water as a reactant or medium^[4]. Stored intact at −20°C, properly lyophilized peptides typically maintain stability for 12-24+ months^[4].

The transit risk most labs underweight

Heat is the obvious risk, every 10°C rise approximately doubles the rate of chemical degradation in most peptides^[4]. But moisture ingress through a compromised seal is often the bigger threat: a vial with a failed seal exposed to ambient humidity for 24 hours can degrade more than an intact vial that briefly hits 45°C in transit^[4].

For short shipping windows (1-3 days) with proper sealing and packaging, full cold-chain logistics may not be strictly required^[4]. For longer transit, cold packs or dry ice with insulated packaging is the published recommendation. The non-negotiable is the seal: vacuum-sealed, intact, vial integrity verifiable on arrival.

Before placing a first order with any new supplier, work through the following five questions. If a supplier can't satisfy them with documentation, not assertions, it's a hidden variable in your study design.

• Is the HPLC chromatogram for my specific batch available before I order?
• Is mass spectrometry confirming molecular identity included on the same COA?
• Is the testing third-party, or in-house only?
• Is the COA archived and retrievable a year from now if I need to defend my methodology?
• Is the material lyophilized and vacuum-sealed, with stated storage and shipping protocols?

None of these questions are aggressive. They're the floor of what the published quality guidance for synthetic peptides considers complete documentation. Any serious supplier will answer them in seconds.